Polygen Pharmaceuticals Lie
FDA inspection history in Edgewood, New York, 2015
- 1
- Form 483
Every document, by year
- Form 483
2015: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2015One Form 483, at Edgewood, New York.
Cited most
Across all Polygen Pharmaceuticals Lie observations on file
- 21 CFR 211.110Sampling and testing of in-process materials and drug products1
- 21 CFR 211.22Responsibilities of quality control unit1
The complete Polygen Pharmaceuticals Lie file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Edgewood, New York
One Form 483 · 2015 · 2 observations
Latest: Form 483, Mar 24, 2015 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2015-03-24 | 483 Form 483 | Edgewood, New York | 2 | $99 |
Investigators on these documents
FEI number 3008383084 · most recent document Mar 24, 2015
About Polygen Pharmaceuticals Lie
How many FDA Form 483s has Polygen Pharmaceuticals Lie received?
FDA Intel has 1 Form 483 on file for Polygen Pharmaceuticals Lie; the most recent is dated Mar 24, 2015.
When was Polygen Pharmaceuticals Lie last inspected by FDA?
The most recent FDA inspection document on file for Polygen Pharmaceuticals Lie is a Form 483 dated Mar 24, 2015, for the site in Edgewood, New York.
What did FDA cite at Polygen Pharmaceuticals Lie?
The regulations cited most in the observations on file for Polygen Pharmaceuticals Lie are 21 CFR 211.110 (Sampling and testing of in-process materials and drug products), 1 time; 21 CFR 211.22 (Responsibilities of quality control unit), 1 time.